Abstract:Background: Lung adenocarcinoma, as a common histological type in lung cancer, the overall survival is very low, and the prognosis is poor because it is difficult to find and easily recurs. Therefore, this study aimed to explore the role of the secreted protein beta-1,3-N-acetylglucosaminyltransferase 3 (B3GNT3) in the development of lung adenocarcinoma and to evaluate its potential significance for early clinical biomarker screening. Methods: The mRNA expression profiles of patients with lung adenocarcinoma and normal controls were analyzed via The Cancer Genome Atlas (TCGA) database. Serum samples of clinical lung cancer patients and healthy people were obtained, and the differences in B3GNT3 expression in different stages of lung adenocarcinoma and in healthy tissues were compared. Kaplan-Meier (K-M) curves were drawn to clarify the influence of high and low expression of B3GNT3 on the prognosis of patients. Peripheral blood samples from patients with lung adenocarcinoma and healthy people were obtained clinically, and receiver operating characteristic (ROC) curves were drawn to clarify the sensitivity and specificity of B3GNT3 expression for the diagnosis of lung adenocarcinoma. Lung adenocarcinoma cells were cultured in vitro, the expression of B3GNT3 was knocked down by lentivirus infection. The expression of the apoptosis-associated genes was detected by reverse transcription-polymerase chain reaction (RT-PCR). Results: The secreted protein B3GNT3 is significantly differentially expressed in the serum of patients with lung adenocarcinoma versus normal controls. Subgroup analysis according to lung adenocarcinoma clinical stage showed that the higher the clinical stage of lung adenocarcinoma was, the higher the B3GNT3 expression. Enzyme-linked immunosorbent assay (ELISA) revealed that B3GNT3 expression was significantly increased in the serum of patients with lung adenocarcinoma and significantly decreased after surgery. By inhibiting programmed cell death-ligand 1 (PD-L1), the level of apoptosis was significantly increased and the proliferative capacity was significantly inhibited. In contrast, the level of apoptosis was significantly increased and the proliferation ability was significantly inhibited after simultaneous overexpression of B3GNT3 and inhibition of PD-L1. Conclusions: High expression of the secreted protein B3GNT3 in lung adenocarcinoma is closely related to prognosis and can serve as a potential biological marker for the early screening of lung adenocarcinoma.

Clinical significance of insulin like growth factor binding protein 3 in patients with lung cancer

Clinical Significance of Insulin-like Growth Factor 1 and Insulin Like Growth Factor Binding Protein 3 in Serum of Patients with Lung Cancer

Igfbp, A Novel Target of Lung Cancer?

Effect of insulin like growth factor binding protein 3 on non-small cell lung cancer

Expression Profile, Clinical Significance, and Biological Function of Insulin-Like Growth Factor 2 Messenger RNA-binding Proteins in Non–small Cell Lung Cancer

Insulin-like Growth Factor Binding Protein-2 Level is Increased in Blood of Lung Cancer Patients and Associated with Poor Survival.

Association Between Circulating Levels Of Igf-1 And Igfbp-3 And Lung Cancer Risk: A Meta-Analysis

Expression and clinical study of vascular endothelial growth factor and its receptors FLT-1, FLK-1/KDR in non-small cell lung cancer

Plasma Levels Of Insulin-Like Growth Factor-I And Lung Cancer Risk: A Case-Control Analysis

The role of IGFBP-3 in tumor development and progression: enlightenment for diagnosis and treatment

Prognostic and diagnostic value of circulating IGFBP2 in pancreatic cancer

Study on the significance of tumor markers in bronchoalveolar lavage fluid for diagnosis of primary lung cancer

Serum insulin-like growth factor binding protein-3 as a potential biomarker for diagnosis and prognosis of oesophageal squamous cell carcinoma

A study on the association among serum insulin,IGFBP3, and endometrial cancer risk in Chinese women

[Serum Levels of Endostatin and VEGF in Non-Small Cell Lung Cancer Patients and the Relationship with the Clinical Pathophysiological Characteristics].

Overexpression of Golph3 is Associated with Poor Survival in Non-Small-Cell Lung Cancer

[Correlation of the Expression of III Β-Tubulin and MDR1 Protein with Biological Features of Non-Small Cell Lung Cancer].

The Relationships Between the Serum Levels of Β2-Mg, VEGF, Bfgf, and IL-6 in Patients with Diffuse Large B Cell Lymphoma and Parameters of International Prognostic Index

The Oncogenic Functions of Insulin-like Growth Factor 2 mRNA-Binding Protein 3 in Human Carcinomas

Insulin Growth Factor-2 Binding Protein 3 (igf2bp3) to Promote Lung Tumorigenesis Viaregulation of P53 Stability.

Experimental study on the suppressive effect of B3GNT3 on the apoptosis of lung adenocarcinoma cells and its application in early screening for lung adenocarcinoma